Aniko Szabo, PhD

Biostatistical Consulting Center Director and Professor

Locations

Biostatistics

Contact Information

Education

PhD - Applied Statistics, University of Memphis, Memphis, TN, 1998
MS - Statistics, University of Memphis, Memphis, TN, 1997
MS - Mathematics, Eötvös University, Budapest, Hungary, 1994

Research Experience

Mathematical Modeling of Cancer Screening and Oncogenesis.

Leadership Positions

Director of the Biostatistics Consulting Center

Research Interests

Dr. Aniko Szabo is a Professor and Director of the Biostatistics Consulting Service. Dr. Szabo's research interests are in statistical modeling of biomedical data. She has worked on analysis methods for PCR and microarray data, developing tree models of oncogenesis, nonparametric models of clustered discrete data, and population level models of the effect of screening on prostate cancer incidence. She collaborates with biomedical investigators across the entire spectrum of translational research from analyzing cellular assays, animal experiments, and observational studies in patients to designing prospective clinical trials and evaluation of policy impacts in national databases.

Curriculum Vitae

Skin injury: Associations with variables related to perfusion and pressure.

(Roberts CJ, Popies JA, Razzak AN, Fang X, Falcucci OA, Pearson PJ, Szabo A.) Anaesth Intensive Care. 2024 Nov;52(6):386-396 PMID: 39394874 SCOPUS ID: 2-s2.0-85206618501 10/12/2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.

(Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M.) Br J Haematol. 2024 Nov;205(5):1830-1834 PMID: 39192546 SCOPUS ID: 2-s2.0-85202177578 08/28/2024
Subclinical brain manifestations of repeated mild traumatic brain injury are changed by chronic exposure to sleep loss, caffeine, and sleep aids.

(Everson CA, Szabo A, Plyer C, Hammeke TA, Stemper BD, Budde MD.) Exp Neurol. 2024 Nov;381:114928 PMID: 39168169 SCOPUS ID: 2-s2.0-85201764724 08/22/2024
Thoracic irrigation for prevention of secondary intervention after thoracostomy tube drainage for hemothorax: A Western Trauma Association multicenter study.

(Carver TW, Berndtson AE, McNickle AG, Boyle KA, Haan JM, Campion EM, Biffl WL, Carroll AN, Sise MJ, Berndt KS, Burris JM, Kopelman TR, Blank JJ, Seamon MJ, Peschman JR, Morris RS, Kugler NW, Conrardy RD, Szabo A, de Moya MA.) J Trauma Acute Care Surg. 2024 Nov 01;97(5):724-730 PMID: 38764139 SCOPUS ID: 2-s2.0-85207595483 05/20/2024
Patient-reported satisfaction with telemedicine in light chain (AL) amyloidosis care.

(Akinola I, Flynn KE, Szabo A, Finkel M, D'Souza A.) Amyloid. 2024 Sep;31(3):235-237 PMID: 38764391 PMCID: PMC11330728 SCOPUS ID: 2-s2.0-85193705751 05/20/2024
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.

(Chakraborty R, Cheruvalath H, Patwari A, Szabo A, Schinke C, Dhakal B, Lentzsch S, D'Souza A, Mohyuddin GR, Julian K, Midha S, Costello P, Kaiser M, Hing MNL, Harrison SJ, Cliff ERS, Mohan M.) Blood Cancer J. 2024 Aug 12;14(1):137 PMID: 39134535 PMCID: PMC11319778 SCOPUS ID: 2-s2.0-85201250452 08/13/2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis.

(Alsouqi A, Ahmed G, Wang J, Cassanello G, Szabo A, Rojek AE, Riedell PA, Awan F, Samples L, Shadman M, Hu M, Bachanova V, Wesson W, Ahmed N, Iqbal M, Kharfan-Dabaja MA, Scordo M, Johnson PC, Chen YB, Ito S, Hamadani M, Frigault M.) Am J Hematol. 2024 Aug;99(8):1624-1627 PMID: 38769663 SCOPUS ID: 2-s2.0-85193730657 05/21/2024
CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience.

(Ahmed G, Alsouqi A, Szabo A, Samples L, Shadman M, Awan FT, Rojek AE, Riedell PA, Iqbal M, Fenske TS, Kharfan-Dabaja MA, Ito S, Hamadani M.) Blood Adv. 2024 Jul 09;8(13):3528-3531 PMID: 38701405 PMCID: PMC11261102 SCOPUS ID: 2-s2.0-85198252267 05/03/2024
The Prevalence and Influence of New or Worsened Neck Pain After a Sport-Related Concussion in Collegiate Athletes: A Study From the CARE Consortium.

(King JA, Nelson LD, Cheever K, Brett B, Gliedt J, Szabo A, Dong H, Huber DL, Broglio SP, McAllister TW, McCrea M, Pasquina P, Feigenbaum LA, Hoy A, Mihalik JP, Duma SM, Buckley T, Kelly LA, Miles C, Goldman JT, Benjamin HJ, Master CL, Ortega J, Kontos A, Clugston JR, Cameron KL, Kaminski TW, Chrisman SP, Eckner JT, Port N, McGinty G.) Am J Sports Med. 2024 Jun;52(7):1845-1854 PMID: 38742422 SCOPUS ID: 2-s2.0-85195228285 05/14/2024
Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis.

(Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A.) Blood Cancer J. 2024 May 26;14(1):61 PMID: 38796476 PMCID: PMC11127981 SCOPUS ID: 2-s2.0-85194268737 05/26/2024
Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.

(Mehdi M, Szabo A, Shreenivas A, Thomas JP, Tsai S, Christians KK, Evans DB, Clarke CN, Hall WA, Erickson B, Ahmed G, Thapa B, McFall T, George B, Kurzrock R, Kamgar M.) Ther Adv Med Oncol. 2024;16:17588359241253113 PMID: 38770091 PMCID: PMC11104030 SCOPUS ID: 2-s2.0-85193752803 05/21/2024
Prospective validation of a hospital triage predictive model to decrease undertriage: an EAST multicenter study.

(Biesboer EA, Pokrzywa CJ, Karam BS, Chen B, Szabo A, Teng BQ, Bernard MD, Bernard A, Chowdhury S, Hayudini AE, Radomski MA, Doris S, Yorkgitis BK, Mull J, Weston BW, Hemmila MR, Tignanelli CJ, de Moya MA, Morris RS.) Trauma Surg Acute Care Open. 2024;9(1):e001280 PMID: 38737811 PMCID: PMC11086287 SCOPUS ID: 2-s2.0-85192362128 05/13/2024